Infusion of atriopeptin into humans and animals induces diuresis, natriuresis, hemodynamic changes, and an increase in arterial hematocrit. The objective of the present study was to elucidate the mechanism(s) responsible for the increase in hematocrit in rats given atriopeptin-24 (AP-24). Infusion of AP-24 for 30 minutes increased large vessel and total vascular hematocrits by 10-15% while decreasing microvascular hematocrits by 9-26% in numerous tissues. Regional vascular permeation by [ 
T he cardiac atria synthesize and store a peptide hormone, atriopeptin, which exhibits potent natriuretic, diuretic, and hemodynamic activity. 1 A variety of physiological or pharmacological circumstances that increase atrial volume or stretch, namely acute volume expansion, 23 vasoconstrictors, 4 and water immersion, 5 results in the discharge of a 28-amino acid peptide, atriopeptin-28 (AP-28) into the circulation. 6 Certain pathophysiological states such as hypertension, 7 congestive heart failure, 8 paroxysmal atrial tachycardia, 9 renal failure, 10 and conditions that would also be expected to modify cardiac volume or pressure result in elevated plasma atriopeptin levels. The diuresis, natriuresis, and vasodilation produced by the peptide in physiological, pharmacological, and pathological circumstances would be expected to reduce intra-atrial volume and/or pressure. In both experimental animals and patients, 1112 exogenous administration of atriopeptin 13 causes an elevation of the hematocrit. This hemoconcentration in normal patients is not merely the result of a negative body fluid balance. 12 Furthermore, bilateral nephrectomized or splenectomized rats also exhibit an increase in hematocrit. 14 The pathophysiological implications of a change in hematocrit induced by elevated plasma atriopeptin levels, especially during cardiovascular or renal disease states, warrants elucidation of the mechanisms involved, which is the subject of this study.
Materials and Methods
Male Sprague-Dawley rats (250-350 g) were anesthetized with Inactin (80 mg/kg i.p.). The femoral vein and femoral artery were cannulated with PE-50 tubing (Clay Adams, Parsippany, New Jersey) for peptide or solvent infusion, blood sampling, and monitoring of blood pressure. Atrial peptides (or saline solvent) were infused at 10 /il/min in 5% dextrose and 0.225% sodium chloride. Atriopeptin-24 (AP-24) designates the 24-amino acid peptide that differs from the circulating form since it lacks the N terminal Ser-Leu-Arg-Arg residues. AP-24 and AP-28 exhibit comparable biological potency as vasodilators and natriuretics-diuretics in rats. 15 AP-21 is a 21-amino acid peptide that differs from AP-24 since it lacks the Phe-Arg-Tyr from the C terminus. AP-21 is much less potent as a blood vessel relaxant and diuretic than AP-24 or AP-28. 3 Since maximal effects of atriopeptin on hematocrit are observed by 30 minutes, we have carried out all of the following studies within that time frame.
The AP-24 used in these experiments was synthesized by us and purified by high-performance liquid chromatography. The absence of contaminant peptides was verified by repeat amino acid sequence analysis. 
Radiolabeled

Hematocrit Determinations
Arterial (large vessel) hematocrit. The hematocrit in samples of heparinized blood obtained from the carotid artery or from the tail vein was assessed by an isotope dilution method as well as by conventional centrifugation techniques. For the centrifugation method, blood was drawn into heparinized microhematocrit capillary tubes and centrifuged for 4 minutes at 13,460# in an IEC Microcapillary Centrifuge (model MB, Needham, Massachusetts).
Because of the possibility that AP-24 might alter mean cell volume and/or red cell deformability (which would influence red cell packing and estimates of hematocrit derived by conventional centrifugation techniques), we used isotope dilution techniques in addition to centrifugation techniques to assess mean red cell volume as well as large vessel hematocrits before and after AP-24 infusion. For this procedure, aliquots of ["CoJEDTA in phosphate-buffered saline were added to aliquots of blood previously drawn into heparinized syringes at the beginning and at the end of the AP-24 infusion. After thorough mixing, aliquots of blood were taken for determination of red cell counts in a Coulter counter (model ZM, Hialeah, Florida) and quantification of [ 57 Co]EDTA counts in aliquots of whole blood and in plasma. These data provided the information needed to calculate the hematocrit (i.e., plasma volume and total red cell volume), as well as mean red cell volume.
Microvascular hematocrits. In addition, the clearance of radiolabeled albumin also will be underestimated if steady-state conditions are achieved before the end of the 30-minute tracer circulation time, that is, if the rate of removal of extravascular tracer in a tissue equals the rate of permeation into the extravascular space from the vasculature before the end of the experiment.
The rats were anesthetized with Inactin (80 mg/ kg), the trachea was cannulated for maintenance on a mechanical respirator, and cannulas were placed in the carotid artery for monitoring blood pressure and in the iliac vein for injection of radiolabeled tracers and for infusion of AP-24. At 0 time, [ ]BSA (the vascular space marker) was injected. Two minutes later, 2 ml blood was withdrawn from the carotid artery into a heparinized syringe, the chest was opened, the heart was excised, and various tissues were removed for quantification of tracers by gamma spectrometry. Before counting, each tissue was rinsed briefly in saline to remove any blood contaminating tissue surfaces.
Vascular permeation (clearance) by [ 
Assessment of Blood Flow and Resistance
In order to assess effects of AP-24 on blood flow, a withdrawal pump was attached via a cannula to an iliac artery and the trachea was cannulated for maintenance on a mechanical respirator as in previous studies. 19 Three minutes before the end of a 30-minute infusion of AP-24 or diluent, the chest cage was opened. Two minutes later (1 minute before the end of the 30-minute AP-24 infusion) 15 y.m "Sr-labeled microspheres were injected into the chamber of the left ventricle. At the end of the 30-minute infusion of AP-24, the withdrawal pump was stopped, the heart was excised, and various tissues were sampled for determination of their content of "Sr-labeled microspheres. Blood flow was determined from the content of "Sr-labeled microspheres in the tissues and in the withdrawal pump blood sample and the pump withdrawal rate using the following formula: 
Data Tabulation and Statistical Analyses
Quantification of radiolabeled tracers in tissue, blood, and plasma was performed in a LBK 1282 Compugamma counter interfaced with a HewlettPackard 1000A computer (Palo Alto, California).
At least 10,000 counts were obtained for each isotope in all of the tissues sampled except the retina and aorta, in which radiolabeled albumin counts ranged from 1,000 to 6,000 counts. Thus, the accuracy of the counts in retina and aorta was decreased somewhat to ±5-10%. The number of microspheres in each tissue sampled exceeded 400 except in the retina in which only ~80 microspheres were present in the combined retinas from each animal. Although it is desirable to obtain at least 380 microspheres per tissue sampled for estimating blood flow, the alternative is to use sufficient numbers of animals to compensate for the increased variance inherent to estimates based on smaller numbers of microspheres per tissue sample. 19 The stored data were then corrected for background and spillover before determination of distribution volumes, clearance, and blood flow. The data were expressed as mean±SD unless indicated otherwise, and differences between groups were assessed by Student's t test.» Effects of AP-24 on parameters assessed in individual rats were assessed by the paired t test.
Results
Effects of AP-24 on Vascular Hematocrits
Infusion of AP-24 caused a time-dependent increase in large vessel hematocrit in rats ( Figure  1) utes, peaked by 30 minutes, and only slowly recovered after termination of peptide infusion. The increased hematocrit induced by AP-24 was dosedependent, requiring a minimum of 100 ng/kg/min to produce a significant increase (Figure 2 ). Neither bilateral nephrectomy nor splenectomy of rats inhibited the AP-24-induced increase in hematocrit (Table  1) , thereby confirming the data of Fluckiger et al.
14 AP-21 produced a marginal effect on hematocrit being much less potent than AP-24. The magnitude of the increase in arterial hematocrit of AP-24-infused rats (versus baseline values) assessed by isotope dilution methods was comparable (Table 2) to the increases obtained by the centrifugation 
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Atriopeptin-24 was infused at 300 ng/kg/min for 30 minutes. Tail vein blood samples were taken for determination of hematocrits from all animals just before and at the end of atriopeptin infusion. Nephrectomized rats were anesthetized with sodium pentobarbital (i.p.) and the kidneys were removed 4 hours before atriopeptin infusion. Sham animals had abdominal surgery similar to nephrectomy. Splenectomized animals had spleens removed 7 days before atriopeptin infusion with sham-operated animals similarly treated.
•Mean±SEM. technique (Tables 1, 3 , and 4). Total vascular hematocrit after AP-24 infusion was -12.3% higher than that in control rats (Table 3) ; this increase in total vascular hematocrit exceeded the difference in arterial hematocrit which was only -1.1% in this particular experiment. In contrast to the marked increase in large vessel hematocrit in AP-24-infused rats, microvascular hematocrits were significantly decreased (Table 4) in ocular tissues (11-18%), the heart (-10%), skeletal muscle (9%), stomach (12%), ileum (26%), cecum (19%), and kidney (20%). Microvascular hematocrits were not significantly altered in lungs, liver, spleen, brain, and skin.
Effects of AP-24 on the Volumes of Distribution of[ m I]BSA and^CojEDTA, on the Volume of Circulating Red Cells, on Mean Red Cell Volume, and on Plasma Volume
The distribution volume of [ 125 I]BSA (injected at the beginning of AP-24 infusion and allowed to circulate for 30 minutes) was -16% larger (p<0.001) than that of rats infused with the vehicle (Table 3) . Plasma volume (based on dilution of [ 125 I]BSA after a 2-minute circulation time) was significantly decreased by ~16% in AP-24-infused rats (p<0.025). In control rats, the distribution volume of [ I25 I]BSA after a tracer circulation time of 30 minutes (during infusion of vehicle) was 4.42 ml/100 g body wt. Of this amount, 3.86 ml (87%) was intravascular plasma, and the remainder (13%) was extravascular (Table 3) . After 30 minutes of AP-24 infusion, the distribution volume of [ I31 I]BSA was 5.12 ml/100 g body wt, of which only 3.13 ml (61%) was intravascular plasma and the remainder (39%) was extravascular. Thus, three times as much radiolabeled albumin permeated the vasculature into the (12) The distribution volume of ["ColEDTA (corrected for, and exclusive of, the tracer content in the kidneys and urine) was identical in rats infused with AP-24 and in those infused with the vehicle (Table 3) . Neither the total volume of circulating red cells (Table 3 ) nor mean red cell volume (Table  2) was affected by AP-24 infusion.
Effects of AP-24 on Vascular Permeation by [ I3I I]BSA
Estimates of regional vascular clearance of [ 131 I]BSA and TPIRm I/ l23 I were significantly increased (~2-5.6-fold) by AP-24 in spleen (x2.2), cecum (x2.3), ileum (x2.8), stomach (x5.6), kidney (x3.2), aorta (x3.9), forelimb muscle (x3), skin (x3.8), and ocular tissues (anterior uvea, x2.20; choroid, x3.4) ( Table 5 ). Albumin permeation was not increased in brain, retina, heart, lung, and liver. In most tissues in which albumin permeation and TPIRm I/ l23 I were increased, TPIR-I/Co values (assessed after 30 minutes of tracer circulation) also were significantly elevated (Table 6 ). Although the magnitude of the TPIR-I/Co. increases tended to be smaller than that of TPIR-I31 I/ I25 I, in the atrium TPIR-I/Co was actually decreased in AP-24-infused rats versus controls. AP-24 infusion had no effect on TPIR-I/Co in the brain, lung, retina, and spleen. 
Effect of AP-24 on Regional Blood Flow and Vascular Resistance
In every tissue examined except in the cecum and atrium, vascular resistance was significantly decreased, and in tissues in which vascular resistance was decreased, blood flow was increased with the exception of the brain, anterior uvea, and ileum (Table 7) .
Discussion
Hematocrit Changes
The AP-24-induced increases in arterial hematocrit in these experiments are consistent with those reported by many other investigators in rats and humans. The finding that the arterial hematocrit was increased (in AP-24-infused rats) with the isotope dilution method (Table 2) indicates that the increase in hematocrit is not (entirely) attributable to decreased deformability of red cells, since the isotope dilution method of assessing hematocrit is not influenced by the extent of red cell packing. The finding that mean red cell volume was not altered in AP-24-infused rats (Table 2) is consistent with this conclusion and indicates that AP-24 does not induce red cell swelling. These observations are consistent with those of Fluckiger et al. 14 The increase in total vascular hematocrit by AP-24 is consistent with the increase in arterial hematocrit and the decrease in plasma volume (Table 3 ). In view of the marked decrease in microvascular hematocrit in many tissues of AP-24-infused rats, and the fact that the precise volumes of blood represented by arterial hematocrit and microvascular hematocrit are not known, the importance of the increase in total vascular hematocrit is that it excludes the possibility that AP-24-induced changes in arterial hematocrit may primarily reflect a redistribution of red cells and plasma between large and small vessels independent of the decrease in plasma volume. Furthermore, the demonstration that the total volume of circulating red cells was identical in AP-24 and in control rats (Table 3) indicates that red cells were not recruited from noncirculating pools by AP-24 (which is in agreement with the observation of Fluckiger et al 14 ) and supports the conclusion that the increase in arterial hematocrit induced by AP-24 is mediated primarily by the decrease in plasma volume (Table 3 ). All of these observations and interpretations are consistent with the increased volume of distribution of [ (Table 3 ) and the marked increase in the rate of vascular permeation by radiolabeled albumin in many tissues ( Table 5 ). The finding that 13% of [ I25 I]BSA injected at the beginning of vehicle infusion was extravascular after 30 minutes of tracer circulation is consistent with transcapillary escape rates for radiolabeled albumin of 0.73%/min and 0.56%/min in normal rats reported by Wraight 21 and Kaysen et al, 22 respectively.
Significance of Microvascular Hematocrit Changes
Although the marked changes in microvascular hematocrit cannot account for AP-24 increases in arterial or total vascular hematocrits, they are nevertheless of considerable interest. In view of evidence that microvascular hematocrits have been reported to increase markedly under conditions of increased blood flow and vasodilation associated with decreased vascular resistance, 23 - 25 an increase in microvascular hematocrit would have been predicted in the present experiments. The finding that microvascular hematocrits were instead significantly reduced, despite associated marked decreases in vascular resistance in many different tissues suggests that other factors may play an important permissive-modulating role in microvascular hematocrit changes associated with changes in vascular resistance. One potentially important factor may be the relationship between changes in blood pressure and vascular resistance. In the studies cited above, 23 -25 vasodilation and blood flow increases were induced locally by topical application of vasodilators and/or by electrically stimulated exercise of an isolated muscle, which did not affect systemic blood pressure. After AP-24 infusion in the present experiments, systemic blood pressure was significantly reduced, and, in a number of tissues in which resistance was decreased, blood flow was not increased; in other tissues, the percent decrease in vascular resistance tended to exceed the expected percent increase in blood flow. In addition, we do not know to what extent AP-24 may cause dilation of the microvasculature distal to resistance arterioles, and/or influence other factors known to modulate microvascular hematocrit 24 - 23 including, for example, mean red cell velocity and plasma velocity through the microvasculature and the percentage of vessels containing red cells.
It is of interest that the effects of AP-24 infusion on vascular resistance and blood flow in this study are not in agreement with the increased resistance and decreased blood flow in various tissues reported by Lappe et al 26 in conscious Wistar rats and by Pegram et al 27 in conscious Wistar-Kyoto rats. On the other hand, our findings are in good general agreement with those of Ackermann et al 28 who observed a decrease in total peripheral resistance in anesthetized male Sprague-Dawley rats and with those of Garcia et al 29 in conscious male SpragueDawley rats. The latter investigators observed an increase in total splanchnic blood flow as well as increased blood flow to the kidney and other tissues consistent with a generalized decrease in vascular resistance. The explanation for these discrepancies in effects of atriopeptin on blood flow and vascular resistance is unclear.
The physiological impact of the decrease in microvascular hematocrit could be twofold. First, it would tend to decrease viscous resistance in the microvasculature. This effect would facilitate flow of blood through the vessels and also tend to reduce permeation of plasma water and solutes across vessel walls. If the reduction in microvascular hematocrit is not offset by a proportional increase in blood flow, delivery of oxygen to tissues could be impaired. Of the tissues assessed in the present experiments, this situation could arise in the atrium itself and in the large and small bowel.
Vascular Permeation Changes
Vascular clearance of radiolabeled albumin in tissues of rats infused with the vehicle were similar (they were the same or differed by no more than a factor of 3) in heart, brain, skeletal muscle, and skin to values reported by Haraldsson et al 17 and by Renkin et al 18 ; however, in the intestinal tract and in the lungs, clearance values reported by Haraldsson et al 17 were 4-12 times higher than in our experiments. These differences may relate to differences in anesthetic agents used, the fact that Haraldsson et al used normal lactating female rats whereas we used normal male rats, and the rats in our experiments received a continuous infusion of vehicle.
AP-24 markedly increased the rate of radiolabeled albumin permeation of the vasculature ( x 2 -5.6) in many, but not all, tissues. The observation that TPIR-I/Co increases tended to correspond to increases in albumin clearance (Tables 5 and 6 ), but were consistently smaller than increases in TPIR- Table 3 ), suggests that AP-24-induced increases in albumin permeation of vessels were not associated with the development of significant tissue edema or any change in systemic extracellular fluid volume (the only possible exception was the atrium in which TPLR-I/Co was decreased despite a significant increase in TPIR-I3I I/ I25 I). This interpretation is supported by the observation that the ~0.7 ml increase in the distribution volume of [ I25 I]BSA injected before infusion of AP-24 was in close agreement with the ~0.6 ml decrease in plasma volume which is identical to the decrease in plasma volume reported by Almeida et al. 30 This 16% decrease in plasma volume corresponds to a ~9% decrease in total blood volume.
The marked reduction in plasma volume by AP-24 implies a shift of plasma water across vessel walls into the interstitium. It is of interest in this regard that Huxley et al 31 observed a ~3.8-fold increase in hydraulic conductivity in frog mesentery capillaries perfused with synthetic human atriopeptin (independent of changes in filtration surface area and/or capillary pressure). However, an increase in hydraulic conductivity without an increase in capillary pressure would merely increase bidirectional flux across the vasculature and would not cause a decrease in plasma volume. On the other hand, an increase in capillary hydrostatic pressure (even in the absence of any change in hydraulic conductivity or capillary oncotic pressure) could cause a shift of fluid from plasma to the extravascular space. Thus, both the decrease in plasma volume and the increased vascular clearance and extravascular distribution of [ 131 I]BSA in our experiments could be accounted for by increased capillary pressures. While capillary pressures were not measured in the present studies, the marked decrease in vascular resistance observed in most tissues, coupled with the relatively small decrease in mean arterial blood pressure, would very likely result in increased capillary pressures. If the increase in hydraulic conductivity observed by Huxley et al in the frog also occurs in mammals, it would of course potentiate the effects of increased capillary pressures in moving plasma proteins as well as water across vessel walls.
In view of the large number of tissues in which radiolabeled albumin permeation was increased by AP-24, it is of interest that albumin permeation also is selectively increased in multiple tissues following systemic injection of histamine 16 and leukotriene B 4 , 32 and in diabetic rats. 33 The basis for the selective nature of the increase in [ I3I I]BSA clearance is unclear; it is noteworthy, however, that AP-24-induced increases in albumin clearance are not closely linked to increased blood flow; albumin clearance was markedly increased in the anterior uvea, spleen, ileum, and cecum despite the absence of any change in blood flow in these tissues.
In conclusion, these observations provide new evidence that the increase in large vessel hematocrit induced by AP-24 infusion 1) is accompanied by a decrease in (microvascular) hematocrit in many tissues, 2) reflects an increase in overall (i.e., total vascular) hematocrit, and 3) is the consequence of a decrease in plasma volume resulting from a marked increase in the rate of vascular permeation by plasma constituents in multiple tissues.
